Home
>
National Drug Code (NDC)
>
Atriplex Mixture
Atriplex Mixture - 49288-0034-1 - (Atriplex Mixture)
Drug Information of Atriplex Mixture
| Product NDC: | 49288-0034 |
| Proprietary Name: | Atriplex Mixture |
| Non Proprietary Name: | Atriplex Mixture |
| Active Ingredient(s): | .0125; .0125; .0125; .0125 g/mL; g/mL; g/mL; g/mL & nbsp; Atriplex Mixture |
| Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atriplex Mixture
| Product NDC: | 49288-0034 |
| Labeler Name: | Antigen Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA102223 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19740323 |
Package Information of Atriplex Mixture
| Package NDC: | 49288-0034-1 |
| Package Description: | 2 mL in 1 VIAL, MULTI-DOSE (49288-0034-1) |
NDC Information of Atriplex Mixture
| NDC Code | 49288-0034-1 |
| Proprietary Name | Atriplex Mixture |
| Package Description | 2 mL in 1 VIAL, MULTI-DOSE (49288-0034-1) |
| Product NDC | 49288-0034 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atriplex Mixture |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRADERMAL; SUBCUTANEOUS |
| Start Marketing Date | 19740323 |
| Marketing Category Name | BLA |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN; ATRIPLEX WRIGHTII POLLEN |
| Strength Number | .0125; .0125; .0125; .0125 |
| Strength Unit | g/mL; g/mL; g/mL; g/mL |
| Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
